Barber Daniel — SEC Form 4 filings
SEC reporting owner CIK 1742266. 15 Form 4 filings on record with FilingPulse; latest filed 2026-09-16.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-03-11 to 2026-09-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 8 filings — 380,677 shares, $1,774,827 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 180,677 shares @ $4.17 ($753,965) in Aquestive Therapeutics, Inc., filed 2026-03-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | President and CEO, Director | 15 | — | 9 legs · 380,677 sh · $1,774,827 | 14 |
Form 4 filings — Barber Daniel
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | Aquestive Therapeutics, Inc. (AQST) | Sale (S): 25,000 @ $4.82 | EDGAR |
| 2026-09-09 | 4 | Aquestive Therapeutics, Inc. (AQST) | Option exercise/expiry (X): 91,743 @ $0.96 · Option exercise/expiry (X): 91,743 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | Aquestive Therapeutics, Inc. (AQST) | Sale (S): 25,000 @ $4.29 | EDGAR |
| 2026-07-17 | 4 | Aquestive Therapeutics, Inc. (AQST) | Sale (S): 4,631 @ $4.03 · Sale (S): 20,369 @ $4.00 | EDGAR |
| 2026-06-16 | 4 | Aquestive Therapeutics, Inc. (AQST) | Sale (S): 25,000 @ $4.16 | EDGAR |
| 2026-05-18 | 4 | Aquestive Therapeutics, Inc. (AQST) | Sale (S): 8,257 @ $4.29 | EDGAR |
| 2026-05-07 | 4 | Aquestive Therapeutics, Inc. (AQST) | Tax withholding (F): 335,922 @ $4.18 | EDGAR |
| 2026-04-13 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 293,100 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 262,000 @ $0 · Sale (S): 180,677 @ $4.17 · Grant/award (A): 523,000 (derivative) @ $4.29 | EDGAR |
| 2025-09-29 | 4 | Aquestive Therapeutics, Inc. (AQST) | Sale (S): 91,343 @ $6.03 | EDGAR |
| 2025-09-22 | 4 | Aquestive Therapeutics, Inc. (AQST) | Sale (S): 400 @ $6 | EDGAR |
| 2025-03-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 272,000 @ $0 · Tax withholding (F): 29,307 @ $2.65 · Tax withholding (F): 53,998 @ $2.65 · Grant/award (A): 408,000 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4/A | Aquestive Therapeutics, Inc. (AQST) | Tax withholding (F): 56,824 @ $4.88 | EDGAR |
| 2024-03-12 | 4 | Aquestive Therapeutics, Inc. (AQST) | Tax withholding (F): 37,938 @ $4.88 | EDGAR |
| 2024-03-11 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 242,600 @ $0 · Grant/award (A): 363,900 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1742266 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →